Ryvu Therapeutics SA's total assets for Q2 2025 were zł281.19M, a decrease of -11.72% from the previous quarter. PL:RVU total liabilities were zł185.94M for the fiscal quarter, a -6.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.